Literature DB >> 8414495

Characterization of the ret proto-oncogene products expressed in mouse L cells.

M Takahashi1, N Asai, T Iwashita, T Isomura, K Miyazaki, M Matsuyama.   

Abstract

The ret proto-oncogene (proto-ret) encodes a receptor type tyrosine kinase with a cadherin-related sequence in the extracellular domain. To investigate whether the proto-Ret protein functions as a cell adhesion molecule like cadherins, we transfected the human proto-ret gene fused to the SV40 promoter or cytomegalovirus (CMV) promoter into mouse L cells in which cadherins are not expressed. Three transfectants with high levels of expression of the proto-Ret proteins were obtained. The proto-Ret proteins were expressed as 150 kDa and 170 kDa glycoproteins in transfectants as observed in human neuroblastoma cells. Cell fractionation experiments revealed that the 170 kDa protein but not the 150 kDa protein was detected predominantly in the plasma membrane fraction, indicating that the 170 kDa protein represents the mature glycosylated form of the proto-Ret protein present on the cell surface. Both 150 kDa and 170 kDa proto-Ret proteins showed tyrosine kinase activity in immunocomplex kinase assay. It is known that cadherins have Ca(2+)-dependent homophilic binding activity and are resistant to trypsinization in the presence of Ca2+. When L cells expressing the proto-Ret proteins were treated with trypsin in the presence of Ca2+, the 170 kDa protein was resistant to its digestion. On the other hand, it was completely digested in the presence of EGTA, suggesting the possibility that the proto-Ret protein interacts with Ca2+ like cadherins. However, the transfectants did not show clear adhesive properties in cell aggregation assays.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414495

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases.

Authors:  M Kato; T Iwashita; K Takeda; A A Akhand; W Liu; M Yoshihara; N Asai; H Suzuki; M Takahashi; I Nakashima
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

2.  Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Authors:  F Carlomagno; G De Vita; M T Berlingieri; V de Franciscis; R M Melillo; V Colantuoni; M H Kraus; P P Di Fiore; A Fusco; M Santoro
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons.

Authors:  Jorge R Cabrera; Jimena Bouzas-Rodriguez; Servane Tauszig-Delamasure; Patrick Mehlen
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

Review 4.  MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.

Authors:  Jessica Oliboni Scapineli; Lucieli Ceolin; Márcia Khaled Puñales; José Miguel Dora; Ana Luiza Maia
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

Review 5.  Thyroid Cancer: Role of RET and Beyond.

Authors:  Francesca Carlomagno
Journal:  Eur Thyroid J       Date:  2012-03-28

Review 6.  A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.

Authors:  Cristina Romei; Raffaele Ciampi; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2016-02-12       Impact factor: 43.330

7.  A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B.

Authors:  M P Cosma; L Panariello; L Quadro; N A Dathan; O Fattoruso; V Colantuoni
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

8.  Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): immunohistochemical studies.

Authors:  A C Granholm; N Srivastava; J L Mott; S Henry; M Henry; H Westphal; J G Pichel; L Shen; B J Hoffer
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

Review 9.  Central role of RET in thyroid cancer.

Authors:  Massimo Santoro; Francesca Carlomagno
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

10.  Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma.

Authors:  James F Powers; Jaime M Brachold; Arthur S Tischler
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.